Raymond James & Associates’s MetLife MET Stock Holding History

Raymond James & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$65.4M	Buy	792,822 +24,567	+3%	+$1.84M	0.04%	374
2024 Q2	$53.9M	Buy	768,255 +16,559	+2%	+$1.18M	0.04%	395
2024 Q1	$55.7M	Buy	751,696 +4,414	+0.6%	+$308K	0.04%	383
2023 Q4	$49.4M	Buy	747,282 +12,436	+2%	+$778K	0.04%	393
2023 Q3	$46.2M	Sell	734,846 -22,626	-3%	-$1.41M	0.04%	371
2023 Q2	$42.8M	Sell	757,472 -27,274	-3%	-$1.51M	0.04%	404
2023 Q1	$45.5M	Sell	784,746 -106,115	-12%	-$7.16M	0.04%	387
2022 Q4	$64.5M	Buy	890,861 +15,158	+2%	+$1.09M	0.06%	282
2022 Q3	$53.2M	Sell	875,703 -26,433	-3%	-$1.69M	0.05%	304
2022 Q2	$56.6M	Sell	902,136 -21,358	-2%	-$1.41M	0.06%	298
2022 Q1	$64.9M	Sell	923,494 -19,235	-2%	-$1.3M	0.05%	294
2021 Q4	$58.9M	Sell	942,729 -104,306	-10%	-$6.55M	0.05%	332
2021 Q3	$64.6M	Sell	1,047,035 -30,095	-3%	-$1.81M	0.06%	281
2021 Q2	$64.5M	Sell	1,077,130 -15,518	-1%	-$983K	0.06%	281
2021 Q1	$66.4M	Sell	1,092,648 -59,791	-5%	-$3.3M	0.07%	246
2020 Q4	$54.1M	Buy	1,152,439 +60,237	+6%	+$2.61M	0.06%	272
2020 Q3	$40.6M	Sell	1,092,202 -58,841	-5%	-$2.23M	0.05%	305
2020 Q2	$42M	Buy	1,151,043 +770	+0.1%	+$26.8K	0.06%	280
2020 Q1	$35.2M	Sell	1,150,273 -111,049	-9%	-$4.92M	0.06%	279
2019 Q4	$64.3M	Buy	1,261,322 +86,022	+7%	+$4.15M	0.08%	222
2019 Q3	$55.4M	Sell	1,175,300 -20,499	-2%	-$977K	0.08%	233
2019 Q2	$59.4M	Sell	1,195,799 -302,926	-20%	-$14.2M	0.09%	216
2019 Q1	$63.8M	Sell	1,498,725 -9,207	-0.6%	-$407K	0.1%	202
2018 Q4	$61.9M	Sell	1,507,932 -235,804	-14%	-$10.1M	0.11%	175
2018 Q3	$81.5M	Sell	1,743,736 -48,107	-3%	-$2.2M	0.13%	152
2018 Q2	$78.1M	Sell	1,791,843 -1,666	-0.1%	-$77.7K	0.13%	151
2018 Q1	$82.3M	Buy	1,793,509 +18,188	+1%	+$883K	0.15%	133
2017 Q4	$89.8M	Buy	1,775,321 +54,243	+3%	+$2.86M	0.16%	118
2017 Q3	$89.4M	Buy	1,721,078 +184,042	+12%	+$8.96M	0.18%	115
2017 Q2	$75.3M	Buy	1,537,036 +33,470	+2%	+$1.55M	0.16%	122
2017 Q1	$70.8M	Sell	1,503,566 -82,461	-5%	-$3.93M	0.16%	124
2016 Q4	$76.2M	Sell	1,586,027 -59,223	-4%	-$2.72M	0.19%	111
2016 Q3	$65.2M	Buy	1,645,250 +762,182	+86%	+$28.7M	0.18%	126
2016 Q2	$31.3M	Buy	883,068 +45,606	+5%	+$1.78M	0.1%	217
2016 Q1	$32.8M	Buy	837,462 +175,604	+27%	+$6.56M	0.11%	196
2015 Q4	$28.4M	Buy	661,858 +30,061	+5%	+$1.32M	0.1%	211
2015 Q3	$26.6M	Buy	631,797 +20,351	+3%	+$951K	0.11%	204
2015 Q2	$30.5M	Buy	611,446 +123,633	+25%	+$5.85M	0.12%	192
2015 Q1	$22M	Buy	487,813 +18,995	+4%	+$854K	0.1%	231
2014 Q4	$22.6M	Buy	468,818 +178,166	+61%	+$8.46M	0.11%	195
2014 Q3	$13.9M	Buy	290,652 +19,502	+7%	+$947K	0.08%	267
2014 Q2	$13.4M	Sell	271,150 -27,266	-9%	-$1.28M	0.08%	262
2014 Q1	$14M	Buy	298,416 +4,556	+2%	+$209K	0.1%	228
2013 Q4	$14.1M	Buy	293,860 +25,349	+9%	+$1.14M	0.11%	210
2013 Q3	$11.2M	Sell	268,511 -1,029	-0.4%	-$44.3K	0.1%	229
2013 Q2	$11M	Buy	+269,540	New	+$9.91M	0.1%	215

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Raymond James & Associates's MET Position: Q3 2024 in Review

Raymond James & Associates increased its MetLife (MET) stake by 3.2% in Q3 2024, buying an estimated $1.84M and bringing the position to 792,822 shares worth $65.4M. The position accounts for 0.04% of the portfolio, ranked #374.

Raymond James & Associates first reported a position in MET in Q2 2013 and has held it in 46 quarters since. The position peaked at $89.8M in Q4 2017. 1,316 funds tracked by Wall St. Rank hold MET as of Q3 2024.

Raymond James & Associates held 792,822 shares of MetLife worth $65.4M as of Q3 2024.
Raymond James & Associates bought 24,567 MetLife shares in Q3 2024, an estimated $1.84M.
MetLife made up 0.04% of Raymond James & Associates's portfolio in Q3 2024, its #374 holding.
Raymond James & Associates first reported a position in MetLife in Q2 2013 and has held it in 46 quarters since.
Raymond James & Associates's MetLife position peaked at $89.8M in Q4 2017.
1,316 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.